Adienne Pharma & Biotech plans Zurich IPO
Adienne Pharma & Biotech, the Swiss pharmaceutical company specialising in treatments for orphan diseases, has announced its intention to float on the SIX Swiss Exchange.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts